Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions

Key Points

• Sarcopenia is linked to neuromuscular junction dysfunction, highlighting therapeutic targets.
• Key evidence includes mechanisms shared between aging and muscle deterioration—affecting strength and function.
• Analysis of the role of neuromuscular junction in sarcopenia reveals novel therapeutic strategies and targets.
• Implications stress the need for innovative treatments that focus on muscle and neuromuscular interactions.